Georgia Commercial Real Estate Investors Bet on Life Sciences Space

Commercial real estate investors across Georgia are increasingly converting vacant office buildings into life sciences laboratory space, betting that continued biotech industry demand will outlast the broader office market's ongoing struggles with elevated vacancy rates.

The conversions typically require substantial capital investment, including upgraded ventilation systems, reinforced flooring, and specialized utility infrastructure necessary for wet lab research space. Despite the higher upfront cost compared to standard office renovation, investors say demand from life sciences tenants has remained resilient even as broader office leasing has softened.

"Traditional office tenants are still cutting their footprint as hybrid work sticks around, but life sciences companies need physical lab space no matter what — you can't run an experiment over video call," said a commercial real estate investor active in several conversion projects. "That distinction is exactly why we're deploying capital into this asset type right now instead of standard office."

Georgia's growing concentration of biotech and pharmaceutical company operations, anchored by Emory and Georgia Tech research activity, has made the state an increasingly attractive target for these conversions. Several conversion projects are concentrated along the Atlanta BeltLine and near the Emory-Georgia Tech biomedical corridor, historically one of the state's densest life sciences employment clusters.

Real estate analysts caution that life sciences lab demand, while currently strong, is not immune to industry-wide funding cycles that have periodically slowed biotech company growth in the past.